ACM
PRME icon

Alessandra Capital Management’s Prime Medicine PRME Stock Holding History

Alessandra Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
666,603
+241,093
+57% +$801K 1.74% 12
2026
Q1 		$1.48M Buy
+425,510
New +$1.62M 1.26% 24

Other funds holding PRME

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
SWM
Shelton Wealth Management Fort Worth, Texas $255M AUM 34.47% 1-Year Est. Return

Alessandra Capital Management's PRME Position: Q2 2026 in Review

Alessandra Capital Management increased its Prime Medicine (PRME) stake by 57% in Q2 2026, buying an estimated $801K and bringing the position to 666,603 shares worth $2.46M. The position accounts for 1.74% of the portfolio, ranked #12.

Alessandra Capital Management first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Alessandra Capital Management held 666,603 shares of Prime Medicine worth $2.46M as of Q2 2026.
  • Alessandra Capital Management bought 241,093 Prime Medicine shares in Q2 2026, an estimated $801K.
  • Prime Medicine made up 1.74% of Alessandra Capital Management's portfolio in Q2 2026, its #12 holding.
  • Alessandra Capital Management first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Alessandra Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.